in the patient group receiving a bulk-forming product containing stimulant type laxative long-term prior to the study , the need for additional stimulant laxatives during the pure bulk laxative ( 3.0 vs. 3.8/4 weeks , ns ) or magnesium hydroxide treatment ( 2.6 vs. 2.7/4 weeks , ns ) was not more frequent and the frequency of defaecation was not lower than in the patients ( during bulk laxative 11.2 vs. 9.3/4 weeks , ns and during magnesium hydroxide 12.0 vs. 13.7/4 weeks , ns ) who received long-term magnesium hydroxide treatment prior to the study .
C0304553
stimulant laxatives
C0282090
laxative